List view / Grid view
![Male Thai child receiving oral polio vaccine from healthcare worker [Credit: frank60 / Shutterstock.com].](https://www.europeanpharmaceuticalreview.com/wp-content/uploads/Oral-vaccine-300x278.jpg)
![Male Thai child receiving oral polio vaccine from healthcare worker [Credit: frank60 / Shutterstock.com].](https://www.europeanpharmaceuticalreview.com/wp-content/uploads/Oral-vaccine.jpg)
The market is expected to grow at a 6.7 percent CAGR, driven by the increasing prevalence of cancer and cardiovascular diseases, as well as growing interest in biologics.
The smart syringe market should grow due to increasing public awareness surrounding vaccination and the increasing popularity of safety injection devices with manufacturers and healthcare professionals.
Analysis of the designs of Phase II and III efficacy trials for HPV vaccines suggest they overstated their effectiveness against cervical cancer, according to researchers.
Novel approach enables genetic analysis of entire viral life cycle, starting with initial infection...
Researchers have examined the relationship between the HPV vaccination and fertility and identified that the vaccine can improve chances of conception...
Scientists have developed an improved vaccine commonly associated with cervical cancer...
Results from Inovio’s Phase 2b trial with VGX-3100 in treating women with high grade cervical neoplasia have been published.
8 July 2015 | By Victoria White
Genticel has announced that the independent Data Safety Monitoring Board recommends the continuation, per protocol, of its Phase 2 clinical trial of GTL001...
17 June 2015 | By Victoria White
The FDA has cleared Genticel’s IND application to conduct in the US a Phase 1 study of GTL001 in patients infected with HPV 16 and/or 18...
17 June 2015 | By Victoria White
GARDASIL 9 is approved in the EU for active immunisation against premalignant lesions and cancers affecting the cervix, vulva, vagina or anus...
